- An update on shareholder proposals and voting policy changes from the major proxy advisory firms
- Say-on-pay and compensation disclosure trends
- Compensation committee adviser independence and disclosure
- Change to NYSE quorum requirements for equity plan proposals
- Update on the status of Dodd-Frank rules applicable to proxy statements
Panelists include:
- Joshua A. Agen, Foley & Lardner LLP
- Richard H Grubaugh, D.F. King & Co., Inc.
- Patrick McGurn, Institutional Shareholder Services
- John K. Wilson, Foley & Lardner LLP
There is no cost to participate in this program, but pre-registration is required. To participate, please register here. Instructions for accessing the program will be sent as the program date approaches.
We look forward to having you join us. For more information, please visit foley.com/NDI or contact Jennifer Bartz at [email protected].
People
Related Insights
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.
17 February 2025
Foley Viewpoints
6 Steps to Manage Tariff Risks in a Trade War
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import must determine the best strategy to deal with the resulting uncertainties.
25 February 2025
Events
Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks
Join Foley and Lardner LLP partners Greg Husisian, Leah Imbrogno, and Vanessa Miller on Tuesday, February 25, for a Strafford CLE webinar, “Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks.”